5 Catalysts Driving My Expectations Of Accelerated Growth For Palantir (Plus A Word Of Caution)

Summary:

  • I see five catalysts for Palantir’s accelerated growth, including the launch of Warp Speed, new deals in healthcare and oil & gas, DevCon, and the emergence of a “Palantir Mafia”.
  • Palantir’s new platform, Warp Speed, is a spin-off from AIP, aimed at manufacturing and supply chains. This expansion shows AIP’s scalability and opens new market opportunities.
  • The upcoming DevCon, targeted at technical leaders, could accelerate Palantir’s commercial growth by engaging key technical decision-makers in prospective companies.
  • Palantir’s rich valuation (Forward P/E above 100) could lead to a price correction if the company doesn’t significantly raise guidance. However, I view any dip as a buying opportunity.
  • I have increased my stake to 1,860 shares and plan to reach 2,000 by November, reaffirming my bullish stance and $125 price target.

Palantir Technologies office in Palo Alto, California, USA

JHVEPhoto

I last covered Palantir Technologies Inc. (PLTR) in August, arguing how this company might be the world’s best AI stock and disclosing my plan to double my position from 1,000 to 2,000 shares.

I am updating my coverage of


Analyst’s Disclosure: I/we have a beneficial long position in the shares of PLTR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *